I agree with almost all of your points, good work!
However as a 7 years shareholder who held the exact views of your above analysis, I recently started to doubt the business model of Pharmaxis's CEO Gary Philips.
The multi-front "potential", as Gary claimed, can only bring in some one-off payments (via milestone payments) to the company, but those fund were spent over the time to support their salary, bonus and free shares (god tell me how many times Gary Philips has been granted millions of free option, in the meantime the share price dropped to 5 years low).
My conclusion is: there ARE potentials, but do those potentials present meaningful return for shareholders?
It's just a cash making machine for the CEO, board/management team, and their employees.
- Forums
- ASX - By Stock
- SNT
- relevant facts and opinion
SNT
syntara limited
Add to My Watchlist
3.85%
!
5.0¢

relevant facts and opinion, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.0¢ |
Change
-0.002(3.85%) |
Mkt cap ! $81.29M |
Open | High | Low | Value | Volume |
5.2¢ | 5.4¢ | 5.0¢ | $129.6K | 2.508M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 219215 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 19215 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 219215 | 0.051 |
9 | 949931 | 0.050 |
5 | 885400 | 0.049 |
1 | 21000 | 0.048 |
1 | 75000 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 19215 | 1 |
0.054 | 56000 | 1 |
0.055 | 368000 | 4 |
0.057 | 483082 | 1 |
0.058 | 101600 | 2 |
Last trade - 15.53pm 04/07/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online